The molecular basis of natural killer (NK) cell recognition and function

Journal of Clinical Immunology

Volumn 16, Issue 5, 1996, Pages 243-253

  Moretta, Lorenzo ^a,b   Mingari, Maria Cristina ^b   Pende, Daniela ^a   Bottino, Cristina ^a   Biassoni, Roberto ^a   Moretta, Alessandro ^c  

^a CENTRO DI BIOTECNOLOGIE AVANZATE   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c UNIVERSITY OF BRESCIA   (Italy)

Author keywords

natural killer (NK) cells; NK cell function; NK cell receptors; NK cell recognition

Indexed keywords

HLA A ANTIGEN; HLA ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; LYMPHOCYTE RECEPTOR; MEMBRANE PROTEIN;

CELL FUNCTION; DOWN REGULATION; HUMAN; IMMUNOREGULATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE SUBPOPULATION;

EID: 0029842041     PISSN: 02719142     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01541388     Document Type: Review

References (69)

1. Herberman RB, Nunn ME, Lavrin DH: Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumours. I. Distribution of reactivity and specificity. Int J Cancer 16:216-229, 1975
2. Kiessling R, Klein E, Wigzell H: "Natural killer" cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype. Eur J Immunol 5:112-117, 1975
3. Trinchieri G: Biology of natural killer cells. Adv Immunol 47:187-376, 1989
4. Becker S, Fenyö EM, Klein E: The "natural killer" cell in the mouse does not require H-2 homology and is not directed against type or group specific antigens of murine C viral proteins. Eur J Immunol 6:882-885, 1976
5. Herberman RB: NK Cells and Other Natural Effect Cells. New York, Academic Press, 1982, p 1566
6. Reynolds CW, Wiltrout RH: Functions of the Natural Immune System. New York, Plenum Press, 1989, p 506
7. Bancroft GJ: The role of natural killer cells in innate resistance to infection. Curr Opin Immunol 5:503-510, 1993
8. Lanier LL, Phillips J, Hackett J, Tutt M, Kumar V: Natural killer cells: Definition of a cell type rather than a function. J Immunol 137:2375-2380, 1986
9. Mingari MC, Poggi A, Biassoni R, Bellomo R, Ciccone E, Pella N, Morelli L, Verdiani S, Moretta A, Moretta L: In vitro proliferation and cloning of CD3-CD16+ cells from human thymocyte precursors. J Exp Med 174:21-26, 1991
10. Sanchez MJ, Gutiérrez-Ramos JC, Fernàndez E, Leonardo E, Lozano J, Martìnez-AC, Toribio ML: Putative prethymic T cell precursors within the early human embryonic liver: A molecular and functional analysis. J Exp Med 177:19-33, 1993
11. Bellone G, Valiante NM, Viale O, Ciccone E, Moretta L, Trinchieri G: Regulation of hematopoiesis in vitro by alloreactive natural killer cell clones. J Exp Med 177:1117-1125, 1993
12. Moretta L, Ciccone E, Mingari MC, Biassoni R, Moretta A: Human NK cells: Origin, clonality, specificity and receptors. Adv Immunol 55:341-380, 1994
13. Moretta A, Bottino C, Vitale M, Pende D, Biassoni R, Mingari MC, Moretta L: Receptors for HLA-class I-molecules in human natural killer cells. Annu Rev Immunol 14:619-648, 1996
14. Ljunggren H-G, Karre K: In search of the "missing self." MHC molecules and NK cell recognition. Immunol Today 11:237-244, 1990
15. Karre K: An unexpected petition for pardon. Curr Biol 11:613-616, 1992
16. Moretta L, Ciccone E, Moretta A, Höglund P, Öhlen C, Kärre K: Allorecognition by NK cells: Nonself or no self? Immunol Today 13:300-306, 1992
17. Ljunggren HG, Karre K: Host resistance directed selectively against H-2-deficient lymphoma variants: Analysis of the mechanism. J Exp Med 162:1745-1759, 1985
18. Piontek GE, Taniguchi K, Ljunggren H-G, Gronberg A, Kiessling R, Klein G, Karre K: YAC-1 MHC class I variants reveal an association between decreased NK sensitivity and increased H-2 expression after interferon treatment or in vivo passage. J Immunol 135:4281-4288, 1985
19. Storkus WJ, Howell DN, Salter RD, Dawson JR, Cresswell P: NK susceptibility varies inversely with target cell class I HLA antigen expression. J Immunol 138:1657-1659, 1987
20. Karre K, Ljunggren H-G, Piontek G, Kiessling R: Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defense strategy. Nature 319:675-678, 1986
21. Garrido F, Cabrera T, Lopez Nevot MA, Ruiz-Cabello F: HLA-class I antigens in human tumours. Adv Cancer Res 67:155-195, 1995
22. Chadwick BS, Sambhara SR, Sasakura Y, Miller RG: Effect of class I MHC binding peptides on recognition by natural killer cells. J Immunol 149:3150-3156, 1992
23. Storkus WJ, Salter RD, Cresswell P, Dawson JR: Peptide-induced modulation of target cell sensitivity to natural killing. J. Immunol 149:1185-1190, 1992
24. Pantaleo G, Zocchi MR, Ferrini S, Poggi A, Tambussi G, Bottino C, Moretta L, Moretta A: Human cytolytic cell clones lacking surface expression of T cell receptor α/β or γ/δ. Evidence that surface structures other than CD3 or CD2 molecules are required for signal transduction. J Exp Med 168:13-24, 1988
25. Ciccone E, Pende D, Viale O, Di Donato C, Tripodi G, Orengo AM, Guardiola J, Moretta A, Moretta L: Evidence of a natural killer (NK) cell repertoire for (allo)antigen recognition: Definition of five distinct NK-determined allospecificities in humans. J Exp Med 175:709-718, 1992
26. Yokoyama WM, Seaman WE: The Ly49 and NKR-P1 gene families encoding lectin-like receptors on natural killer cells: the NK gene complex. Annu Rev Immunol 11:613-635, 1993
27. Wagtmann N, Biassoni R, Cantoni C, Verdiani S, Malnati MS, Vitale M, Bottino C, Moretta L, Moretta A, Long EO: Molecular clones of the p58 NK cell receptor reveal immunoglobulin related molecules with diversity in both the extra- and intracellular domains. Immunity 2:439-449, 1995
28. Biassoni R, Cantoni C, Falco M, Verdiani S, Bottino C, Vitale M, Conte R, Poggi A, Moretta A, Moretta L: The HLA-C-specific "activatory" or "inhibitory" Natural Killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions. J Exp Med 183:645-650, 1996
29. D'Andrea A, Chang C, Franz-Bacon K, McClanahan T, Phillips JH, Lanier LL: Molecular cloning of NKB1. A natural killer cell receptor for HLA-B allotypes. J Immunol 155:2306-2310, 1995
30. Colonna M, Samaridis J: Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells. Science 268:405-408, 1995
31. Pende D, Biassoni R, Cantoni C, Verdiani S, Falco M, Di Donato C, Accame L, Bottino C, Moretta A, Moretta L: The natural killer cell receptor specific for HLA-A allotypes: A novel member of the p58/p70 family of inhibitory receptors which is characterized by three Ig-like domains and is expressed as a 140 kD disulphide-linked dimer. J Exp Med (in press)
32. Lanier LL, Chang C, Phillips J: Human NKR-P1A. A disulphide-linked homodimer of the C-type lectin superfamily expressed by a subset of NK and T lymphocytes. J Immunol 153:2417-2427, 1994
33. Moretta A, Tambussi G, Ciccone E, Pende D, Melioli G, Moretta L: CD16 Surface molecules regulate the cytolytic function of CD3-CD16+ human "natural killer" cells. Int J Cancer 44:727-730, 1989
34. Bolhuis RL, Roozemond RC, Van de Griend RJ: Induction and blocking of cytolysis in CD2+, CD3- NK and CD2+, CD3+ cytotoxic T lymphocytes via CD2 50 kD sheep erythrocyte receptor. J Immunol 136:3939-3944, 1986
35. López-Cabrera M, Santis AG, Fernandes-Ruiz, Blacher R, Esch F, Sanchez-Mateos P, Sanchez-Madrid F: Molecular cloning, expression, and chromosomal localization of the human earliest lymphocyte activation antigen AIM/CD69, a new member of the C-type animal lectin superfamily of signal- transmitting receptors. J Exp Med 178:537-547, 1993
36. Ziegler SF, Ramsdell F, Hjerrild KP, Armitage RJ, Grabstein KH, Hennen KB, Farrah T, Fanslow WC, Shevach EM, Alderson MR: Molecular characterization of the early activation antigen CD69: A type II membrane glycoprotein related to a family of natural killer cell activation antigens. Eur J Immunol 23:1643-1648, 1993
37. Moretta A, Poggi A, Pende D, Tripodi G, Orengo AM, Pella N, Augugliaro R, Bottino C, Ciccone E, Moretta L: C:D69-mediated pathway of lymphocyte activation. Anti-CD69 mAbs trigger the cytolytic activity of different lymphoid effector cells with the exception of cytolytic T lymphocytes expressing TCR alpha/beta. J Exp Med 174:1393-1398, 1991
38. Burgert HG, Maryanski HL, Kvist S: E3/19K protein of adenovirus type 2 inhibits lysis of cytolytic T lymphocytes by blocking cell-surface expression of histocompatibility class I antigens. Pro Natl Acad Sci USA 84:1356-1360, 1987
39. Del Val M, Hengel H, Häcker I, Hartlaub U, Ruppert T, Lucin P, Koszinowski UH: Cytomegalovirus prevents antigen presentation by blocking the transport of peptide-loaded major histocompatibility complex class I molecules into the medial-golgi compartment. J Exp Med 176:729-738, 1992
40. Lanier LL, Phillips JH: Molecular and cell biology of inhibitory MHC class I receptors on NK cells and T cells. Immunol Today 17:86-91, 1996
41. Glas R, Sturmhöfel K, Hämmerling GJ, Kärre K, Ljunggren HG: Restoration of a tumorigenic phenotype by β2-microglobulin transfection to EL-4 mutant cells. J Exp Med 175:843-846, 1992
42. Bix M, Liao NS, Zijstra M, Loring J, Jaenisch R, Raulet D: Rejection of class I MHC deficient haematopoietic cells by irradiated MHC matched mice. Nature 349:329-331, 1991
43. Ciccone E, Pende D, Viale O, Tambussi G, Ferrini S, Biassoni R, Longo A, Guardiola J, Moretta A, Moretta L: Specitic recognition of human CD3-CD16+ NK cells requires the expression of an autosomic recessive gene on target cells. J Exp Med 172:47-52, 1990
44. Ciccone E, Pende D, Viale O, Di Donato C, Orengo AM, Biassoni R, Verdiani S, Amoroso A, Moretta A, Moretta L: Involvement of HLA class I alleles in NK cell specific functions: Expression of HLA-Cw3 confers selective protection from lysis by alloreactive NK clones displaying a defined specificity (specificity 2). J Exp Med 176:963-971, 1992
45. Moretta A, Vitale M, Bottino C, Orengo AM, Morelli L, Augugliaro, R, Barbaresi M, Ciccone E, Moretta L: P58 molecules as putative receptors for MHC class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class 1-protected cells in NK clones displaying different specificities. J Exp Med 178:597-604, 1993
46. lck kinase. Eur J Immunol 24:2527-2534, 1994
47. Christiansen FT, Witt CS, Ciccone E, Townend D, Pende D, Viale O, Abraham LJ, Dawkins RL, Moretta L: Human natural killer (NK) alloreactivity and its association with the major histocompatibility complex: Ancestral haplotypes encode particular NK-defined haplotypes. J Exp Med 178:1033-1039, 1993
48. Colonna M, Spies T, Strominger JL, Ciccone E, Moretta A, Moretta L, Pende D, Viale O: Alloantigen recognition by human Natural Killer cells is associated with HLA-C or a closely linked gene. Proc Natl Acad Sci USA 89:7983-7985, 1992
49. Colonna M, Borsellino G, Falco M, Ferrara GB, Strominger JL: HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1- and NK2-specific natural killer cells. Proc Natl Acad Sci USA 90:12000-12004, 1993
50. Biassoni R, Falco M, Cambiaggi A, Costa P, Verdiani S, Pende D, Conte R, Di Donato C, Parham P, Moretta L: Amino acid substitutions can influence the NK-mediated recognition of HLA-C molecules. Role of Serine-77 and lysine-80 in the target cell protection from lysis mediated by "group 2" or "group 1" NK clones. J Exp Med 182:605-609, 1995
51. Malnati MS, Peruzzi M, Parker KC, Biddison WE, Ciccone E, Moretta A, Long EO: Peptide specificity in the recognition of MHC class I by natural killer cell clones. Science 267:1016-1018, 1995
52. Ciccone E, Pende D, Vitale M, Nanni L, Di Donato C, Bottino C, Morelli L, Viale O, Amoroso A, Moretta A. Moretta L: Self class I molecules protect normal cells from lysis mediated by autologous natural killer cells. Eur J Immunol 24:1003-1006, 1994
53. Ciccone E, Pende D, Nanni L, Di Donato C, Viale O, Beretta A, Vitale M, Sivori S, Moretta A, Moretta L: General role of HLA class I molecules in the protection of target cells from lysis by NK cells. Evidence that the free heavy chain of class I molecules are not sufficient to mediate the protective effect. Int Immunol 3:393-400, 1995
54. Gumperz JE, Litwin V, Phillips JH, Lanier LL, Parham P: The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative receptor. J Exp Med 181:1133-1144, 1995
55. Vitale M, Sivori S, Pende D, Augugliaro R, Di Donato C, Amoroso A, Malnati M, Bottino C, Moretta L, Moretta A: Physical and functional independency of p70 and p58 NK cell receptors for HLA-class I. Their role in the definition of different groups of alloreactive NK cell clones. Proc Natl Acad Sci USA 183:1453-1457, 1996
56. Litwin V, Gumperz J, Parham P, Phillips JH, Lanier LL: Specificity of HLA class I antigen recognition by human NK clones: Evidence for clonal heterogeneity, protection by self and non-self alleles, and influence of the target cell type. J Exp Med 178:1321-1336, 1993
57. Moretta A, Tambussi G, Bottino C, Tripodi G, Merli A, Ciccone E, Pantaleo G, Moretta L: A novel surface antigen expressed by a subset of human CD3- CD16+ natural killer cells. Role in cell activation and regulation of cytolytic function. J Exp Med 171: 695-714, 1990
58. Moretta A, Bottino C, Pende D, Tripodi G, Tambussi G, Viale O, Orengo A, Barbaresi M, Merli A, Ciccone E, Moretta L: Identification of four subsets of human CD3-CD16+ NK cells by the expression of clonally distributed functional surface molecules. Correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition. J Exp Med 172:1589-1598, 1990
59. Bottino C, Vitale M, Pende D, Biassoni R, Moretta A: Receptors for HLA class I molecules in human NK cells. Semin Immunol 7:67-73, 1995
60. Litwin V, Gumperz JE, Parham P, Phillips JH, Lanier LL: NKB1: a Natural Killer cell receptor involved in the recognition of polymorphic HLA-B molecules. J Exp Med 180:537-543, 1994
61. Moretta A, Vitale M, Sivori S, Bottino C, Morelli L, Augugliaro R, Barbaresi M, Pende D, Ciccone E, Lopez-Botet M, Moretta L: Human Natural Killer cell receptors for HLA-class I molecules. Evidence that the Kp43 (CD94) molecule functions as receptor for HLA-B alleles. J Exp Med 180:545-555, 1994
62. Chang C, Rodriguez A, Carretero M, Lopez-Botet M, Phillips JH, Lanier LL: Molecular characterization of human CD94: A type II membrane glycoprotein related to the C-type lectin superfamily. Eur J Immunol 25:2433-2437, 1995
63. Hofer E, Duckler M, Fuad SA, Houkins JP, Yabe T, Bach FH. Candidate natural killer cell receptors. Immunol Today 13:429-430, 1992
64. Moretta A, Sivori S, Vitale M, Pende D, Morelli L, Augugliaro R, Bottino C, Moretta L: Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells. J Exp Med 182:875-884, 1994
65. Ferrini S, Cambiaggi A, Meazza F, Sforzini S, Marciano S, Mingari MC, Moretta L: T cell clones expressing the NK-related p58 receptor molecule display heterogeneity in phenotypic properties and p58 function. Eur J Immunol 24:2294-2298, 1994
66. Mingari MC, Schiavetti F, Ponte M, Vitale C, Maggi E, Romagnani S, Demarest J, Pantaleo G, Fauci AS, and Moretta L. Human CD8+ T-lymphocyte subsets that express HLA-dass I specific inhibitory receptors represent oligoclonally or monoclonally expanded cell populations. Proc Natl Acad Sci USA (in press)
67. Mingari MC, Vitale C, Cambiaggi A, Schiavetti F, Melioli G, Ferrini S, Poggi A: Cytolytic T lymphocytes displaying natural killer (NK)-like activity: Expression of NK-related functional receptors for HLA class I molecules (p58 and CD94) and inhibitory effect on the TCR-mediated target cell lysis or lymphokine production. Int Immunol 4:697-703, 1995
68. Phillips JH, Gumperz JE, Parham P, Lanier LL: Superantigen-dependent, cell-mediated cytotoxicity inhibited by MHC class I receptor on T lymphocytes. Science 128:403-405, 1995
69. Mingari MC, Vitale C, Schiavetti F, Cambiaggi A, Zunino A, Ponte M: HLA-class I-specific inhibitory receptors of NK type on a subset of human T cells. Chem Immunol (in press)